A950200 Stock Overview
Psomagen, Inc. engages in the provision of multi-omics solutions for clinical and research purposes.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
Rewards
Risk Analysis
Psomagen, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₩5,300.00 |
52 Week High | ₩10,090.00 |
52 Week Low | ₩4,550.00 |
Beta | 0 |
1 Month Change | 6.85% |
3 Month Change | 3.92% |
1 Year Change | -16.01% |
3 Year Change | -57.60% |
5 Year Change | n/a |
Change since IPO | -64.90% |
Recent News & Updates
Shareholder Returns
A950200 | KR Biotechs | KR Market | |
---|---|---|---|
7D | -12.8% | 3.1% | 3.8% |
1Y | -16.0% | 23.4% | 13.0% |
Return vs Industry: A950200 underperformed the KR Biotechs industry which returned 23.4% over the past year.
Return vs Market: A950200 underperformed the KR Market which returned 13% over the past year.
Price Volatility
A950200 volatility | |
---|---|
A950200 Average Weekly Movement | 8.3% |
Biotechs Industry Average Movement | 7.9% |
Market Average Movement | 5.3% |
10% most volatile stocks in KR Market | 12.0% |
10% least volatile stocks in KR Market | 2.4% |
Stable Share Price: A950200 has not had significant price volatility in the past 3 months.
Volatility Over Time: A950200's weekly volatility (8%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2004 | n/a | n/a | https://www.psomagen.com |
Psomagen, Inc. engages in the provision of multi-omics solutions for clinical and research purposes. The company provides genomics, a study of gene sequence and expression; epigenomics, a study of epigenetic changes, such as chromatin assembly, histone modification, and DNA-protein interaction in a cell; metagenomics, a study of genetic material from microorganisms in heterogeneous samples; transcriptomics, a study of RNA and its expression through sequencing, offered to analyze the impact of gene expression on the biology of an organism; and proteomics, a study of all the expressed proteins in an organism (proteome). It also offers Bioinformatics, a software tool and pipeline that helps scientists in analyzing data, as well as provides clinical testing solutions.
Psomagen, Inc. Fundamentals Summary
A950200 fundamental statistics | |
---|---|
Market cap | ₩101.95b |
Earnings (TTM) | ₩0 |
Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs A950200 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
A950200 income statement (TTM) | |
---|---|
Revenue | ₩0 |
Cost of Revenue | ₩0 |
Gross Profit | ₩0 |
Other Expenses | ₩0 |
Earnings | ₩0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
Earnings per share (EPS) | 0 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 0.0% |
How did A950200 perform over the long term?
See historical performance and comparison